“If you hear hoofbeats, you are more likely to see a horse, unless you are in an evolving COVID-19 pandemic. Then it may be a zebra.” — Benji Mathews, MD, of Regions Hospital in St. Paul, Minnesota, on including atypical COVID-19 manifestations in a differential diagnosis.
“These are the very hard realities that essential workers are going through in this pandemic.” — Naheed Dosani, MD, of the University of Toronto and McMaster University, on healthcare workers losing income when quarantining after a COVID-19 exposure.
“Someone who has dedicated themselves to caring for patients with cardiovascular disease using the best available evidence, dedicated themselves to continually improving their own medical knowledge, and dedicated themselves to sharing their expertise with colleagues, patients, and families.” — Geoffrey Barnes, MD, of University of Michigan in Ann Arbor, on what the title of “Fellow of the American College of Cardiology” means to him.
“This new report did not mirror the trials.” — Peter Goadsby, MBBS, of King’s College London in England and the University of California San Francisco, on cases of elevated blood pressure with a migraine prevention drug.
“The reality is folks with rare diseases will never have enough to do the trials out of the gate.” — Tom Maddox, MD, of BJC HealthCare and Washington University School of Medicine in St. Louis, discussing whether patients with pulmonary hypertension and other rare diseases should get the COVID-19 vaccine.
“Any conclusions from this study should not be overstated as inclusive of all ethnicities.” — Brooks Cash, MD, of the University of Texas Health Science Center at Houston, on research showing the benefit of aspirin for decreasing colorectal cancer risk in older people.